Feline Vaccines Market Reaches $2.53 Billion In 2026: Key Developments Shaping Expansion
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Feline Vaccines Market Set To Climb From $1.91 Billion In 2026 To $2.53 Billion By 2030
The market for feline vaccines has experienced significant growth over recent years. This market is projected to expand from $1.77 billion in 2025 to $1.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.6%. Historically, this growth was driven by factors such as an increase in pet adoption, greater awareness regarding feline health, a rise in infectious diseases, improvements in veterinary care infrastructure, and better adherence to routine vaccinations.
The feline vaccines market is anticipated to experience robust expansion in the coming years. It is projected to reach a valuation of $2.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth throughout the forecast period stems from factors such as a heightened demand for sophisticated feline immunization solutions, an increased emphasis on proactive veterinary care, the growing acceptance of multi-component vaccines, augmented investment in biotechnology for companion animals, and a greater focus on vaccinating early in a cat’s life. Key trends anticipated during this period encompass vaccine breakthroughs driven by technology, progress in platforms for recombinant and DNA vaccines, enhancements in systems for adjuvant and antigen delivery, an uptick in research and development within feline immunology, and novel approaches in needle-free and intranasal vaccination techniques.
Get A Free Sample Report With In-Depth Market Insights:
Feline Vaccines Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing pet cat population is projected to stimulate the expansion of the feline vaccines market moving forward. This term, pet cat population, refers to the rising quantity of domesticated cats residing with households for purposes of companionship, emotional support, and recreation. The growth in the pet cat population is attributable to higher pet adoption rates, coupled with a growing understanding of the mental and emotional advantages associated with pet ownership. Feline vaccines play a vital role in diminishing the occurrence of infectious diseases in cats by conferring immunity against conditions such as feline leukemia virus (FeLV), feline panleukopenia, herpesvirus, and calicivirus, thereby extending their lifespan and enhancing their overall health. For example, in June 2025, information from the American Pet Products Association (APPA), a US-based trade association, showed that cat ownership increased by 23 percent in 2024, with the number of households rising from 40 million in 2023 to 49 million in 2024. Therefore, the expanding pet cat population is a primary catalyst for the growth of the feline vaccines market.
Feline Vaccines Market Segment Outlook: Which Categories Are Growing Fastest?
The feline vaccines market covered in this report is segmented –
1) By Vaccine Type: Inactivated (Killed) Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
2) By Disease Type: Feline Panleukopenia Virus (FPV), Feline Calicivirus (FCV), Feline Herpesvirus Type 1 (FHV-1), Feline Leukemia Virus (FeLV), Rabies, Feline Immunodeficiency Virus (FIV), Other disease types
3) By Technology: Live Attenuated, Inactivated, Recombinant deoxyribonucleic acid (DNA), Subunit, Toxoi
4) By Route of Administration: Injectable Vaccines, Intranasal Vaccines, Oral Vaccines
5) By End-User: Veterinary Hospitals, Veterinary Clinics, Animal Research Institutes
Subsegments:
1) By Inactivated (Killed) Vaccines: Whole Virus Vaccines, Split Virus Vaccines, Purified Antigen Vaccines
2) By Live Attenuated Vaccines: Modified Live Virus Vaccines, Temperature Sensitive Mutant Vaccines, Attenuated Viral Vector Vaccines
3) By Recombinant Vaccines: Recombinant Viral Vector Vaccines, Recombinant Subunit Vaccines, Deoxyribonucleic Acid (DNA) Based Recombinant Vaccines
#Feline Vaccines Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies within the feline vaccines market are concentrating on creating sophisticated products, including recombinant vector vaccines, with the aim of increasing effectiveness, improving safety, and offering more extensive defense. These recombinant vector vaccines are cutting-edge immunizations where a benign virus carries particular antigens, thereby prompting a powerful and precise immune reaction against the intended pathogen. An example of this is when, in September 2024, MSD Animal Health, a global animal health company based in the US, secured USDA approval for Nobivac NXT FeLV, which is a feline leukemia virus vaccine utilizing its RNA-particle technology platform. This vaccine represents a next-generation, non-adjuvanted recombinant canarypox vector vaccine specifically for feline leukemia virus (FeLV). The vaccine incorporates a patented technology specifically designed to stimulate strong cell-mediated and humoral immunity, consequently offering improved protection against FeLV infection and related ailments. Furthermore, it delivers a low-volume, subcutaneous dose and is recommended for healthy cats 8 weeks of age or older, with the goal of enhancing safety profiles, simplifying administration, and increasing compliance within veterinary practices.
Feline Vaccines Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the feline vaccines market are Merck & Co. Inc., Boehringer Ingelheim Animal Health GmbH, Zoetis Inc., Intas Pharmaceuticals Ltd., Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Virbac SA, Neogen Corporation, Laboratorios HIPRA S.A., Vetoquinol SA, Indian Immunologicals Limited, Jinyu Bio-Technology Co. Ltd., Ourofino Animal Health S.A., Biogénesis Bagó S.A., Biovet Private Limited, Hester Biosciences Limited, Biovet S.A., Durvet Inc., China Animal Husbandry Group Co. Ltd., Biopharma Laboratory, Kyoto Biken Laboratories Inc., Nisseiken Co. Ltd., Liaoning Yikang Biological Co. Ltd., Torigen Pharmaceuticals Inc., Bioveta a.s.
View The Full Feline Vaccines Market Report:
Feline Vaccines Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the feline vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the feline vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
